Dr. Michael Blaiss expressed his astonishment at patients' reluctance to use auto-injectors when experiencing severe allergic reactions, noting that some even prefer to wait for emergencies.
A new device, Neffy, which delivers epinephrine via nasal spray, aims to alleviate needle aversion among allergy sufferers, with health experts optimistic it will save lives.
Ilana Golant highlighted the consequences of needle fear, recounting instances where anxious parents missed crucial opportunities to administer the EpiPen, leading to hospital admissions.
Dr. Blaiss emphasized the long overdue need for an auto-injector alternative, stating that the approval of Neffy represents a significant advancement in allergy treatment.
[
Collection
]
[
|
...
]